Introduction: Pegfilgrastim, a new era in the management of chemotherapy-induced neutropenia

被引：3
|
作者：
Petros, WP [1 ]
机构：
[1] W Virginia Univ, Mary Babb Randolph Canc Ctr, Morgantown, WV 26506 USA
来源：
PHARMACOTHERAPY | 2003年 / 23卷 / 08期
关键词：
D O I：
10.1592/phco.23.9.1S.32890
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：1S / 2S
页数：2
相关论文
共 50 条
  • [1] Spotlight on Pegfilgrastim in Chemotherapy-Induced Neutropenia
    James E. Frampton
    Gillian M. Keating
    BioDrugs, 2005, 19 : 405 - 407
  • [2] Pegfilgrastim -: Rational drug design for the management of chemotherapy-induced neutropenia
    Lüftner, D
    Possinger, K
    ONKOLOGIE, 2005, 28 (11): : 595 - 602
  • [3] Pegfilgrastim: a review of the pharmacoeconomics for chemotherapy-induced neutropenia
    Rofail, Pierre
    Tadros, Mariam
    Ywakim, Riham
    Tadrous, Mina
    Krug, Allison
    Cosler, Leon E.
    EXPERT REVIEW OF PHARMACOECONOMICS & OUTCOMES RESEARCH, 2012, 12 (06) : 699 - 709
  • [4] Pegfilgrastim: a recent advance in the prophylaxis of chemotherapy-induced neutropenia
    Waladkhani, AR
    EUROPEAN JOURNAL OF CANCER CARE, 2004, 13 (04) : 371 - 379
  • [5] Pegfilgrastim in the primary prophylaxis of chemotherapy-induced severe neutropenia
    Olvera Alberto, Serrano
    Fernando, Alban
    Alberto, Villalobos
    Cwilich Raquel, Gerson
    GACETA MEXICANA DE ONCOLOGIA, 2010, 9 (01): : 3 - 10
  • [6] Once-per-cycle pegfilgrastim (Neulasta) for the management of chemotherapy-induced neutropenia
    Crawford, J
    SEMINARS IN ONCOLOGY, 2003, 30 (04) : 24 - 30
  • [7] Management of chemotherapy-induced neutropenia
    Blundell, Bernardette
    Azzopardi, Lilian M.
    Serracino-Inglott, Anthony
    INTERNATIONAL JOURNAL OF CLINICAL PHARMACY, 2015, 37 (01) : 241 - 241
  • [8] Prevention of Chemotherapy-Induced Neutropenia with Pegfilgrastim: Pharmacokinetics and Patient Outcomes
    Yang, Bing-Bing
    Savin, Michael A.
    Green, Michael
    CHEMOTHERAPY, 2012, 58 (05) : 387 - 398
  • [9] Neulasta (Pegfilgrastim): A once-per-cycle option for the management of chemotherapy-induced neutropenia
    Biganzoli, L
    Untch, M
    Skacel, T
    Pico, JL
    SEMINARS IN ONCOLOGY, 2004, 31 (03) : 27 - 34
  • [10] RGB-02 (biosimilar pegfilgrastim) in the treatment of chemotherapy-induced neutropenia
    Santha, Dora
    Illes, Andras
    Aradi, Ildiko
    Horvat-Karajz, Karoly
    Kahan, Zsuzsanna
    FUTURE ONCOLOGY, 2019, 15 (18) : 2083 - 2092
12345